^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

Abecma (idecabtagene vicleucel)

i
Company:
2seventy bio, BMS
Drug class:
BCMA-targeted CAR-T immunotherapy
Related drugs: